Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 29 Issue 1
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2011  >  29(1): 15-16,70

Jiang Nan, Yang Yong-Ge, Xu Xue-Ting, Zhao Gang-Tao. Determination of Atorvastatin in human plasma by LC-MS-MS[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(1): 15-16,70.
Citation: Jiang Nan, Yang Yong-Ge, Xu Xue-Ting, Zhao Gang-Tao. Determination of Atorvastatin in human plasma by LC-MS-MS[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(1): 15-16,70.
shu

Determination of Atorvastatin in human plasma by LC-MS-MS

  • Department of Pharmacy,General Hospital of Beijing Military Command of PLA,Beijing 100700,China

  • Received Date: 2010-05-18
  • Rev Recd Date: 2010-09-09
  • Objective To establish a method for determining Atorvastatin in human plasma by LC-MS-MS. Methods Atorvastatin was extracted for determination by LC-MS-MS. Analytical column was Thermo BioBasic-C8(2.1 mm×100 mm,5 μm). The mobile phase was acetonitrile(0.1%acid):water(0.1%acid)=70:30. Mass spectrum conditions was ESI performing in the SRM mode using target ions m/z 558→278(30EV)(Atorvastatin ), m/z 269→106(22 EV)(tolbutamide), SP 3 500 KV, SGP 10 Arb, AGP 15 Arb, TEM 314 ℃. Results The calibration curve was linear over the range of 0.1~20 μg/L. The LLOQ of Atorvastatin in plasma was 0.1 μg/L. The extracted recovery was>70%. The intra-and inter-day RSD were<15%. Conclusion The method is sensitive, simple and accurate to determinate Atorvastatin plasma concentration and suitable to study phase I clinical test of Atorvastatin.
  • [1] Plosker GL, Wagstaff AJ. Fluvastatin: a review of its pharmacology and use in the management og hypercholesterolaemia[J]. Drμgs, 1996, 51: 433.
    [2] Naoumova RP, Marais AD, Mountney J,et al. Plasma mevalonic acid, an index of cholesterol synthesis in vivo and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia[J]. Atherosclerosis, 1996, 119: 203.
    [3] 胡晓玲,李环德. UPLC-MS/MS法测定健康人血浆中的阿托伐他汀浓度及药物代谢动力学研究[J].中南药学,2008,6(4):400.
    [4] 董 婧, 陈西敬, 宋 捷, 等. 阿托伐他汀大鼠体内药动学及肠肝循环研究[J]. 中国药科大学学报,2008,39(1):55.
  • 加载中
通讯作者: 陈斌, [email protected]
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(3146) PDF downloads(97) Cited by()

Related
Proportional views

Determination of Atorvastatin in human plasma by LC-MS-MS

  • Department of Pharmacy,General Hospital of Beijing Military Command of PLA,Beijing 100700,China
  • Received Date: 2010-05-18
  • Rev Recd Date: 2010-09-09

Abstract: Objective To establish a method for determining Atorvastatin in human plasma by LC-MS-MS. Methods Atorvastatin was extracted for determination by LC-MS-MS. Analytical column was Thermo BioBasic-C8(2.1 mm×100 mm,5 μm). The mobile phase was acetonitrile(0.1%acid):water(0.1%acid)=70:30. Mass spectrum conditions was ESI performing in the SRM mode using target ions m/z 558→278(30EV)(Atorvastatin ), m/z 269→106(22 EV)(tolbutamide), SP 3 500 KV, SGP 10 Arb, AGP 15 Arb, TEM 314 ℃. Results The calibration curve was linear over the range of 0.1~20 μg/L. The LLOQ of Atorvastatin in plasma was 0.1 μg/L. The extracted recovery was>70%. The intra-and inter-day RSD were<15%. Conclusion The method is sensitive, simple and accurate to determinate Atorvastatin plasma concentration and suitable to study phase I clinical test of Atorvastatin.

Jiang Nan, Yang Yong-Ge, Xu Xue-Ting, Zhao Gang-Tao. Determination of Atorvastatin in human plasma by LC-MS-MS[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(1): 15-16,70.
Citation: Jiang Nan, Yang Yong-Ge, Xu Xue-Ting, Zhao Gang-Tao. Determination of Atorvastatin in human plasma by LC-MS-MS[J]. Journal of Pharmaceutical Practice and Service, 2011, 29(1): 15-16,70.
shu

    HTML

Reference (4)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: [email protected]

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return